Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase	Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, chronic myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Active, not recruiting	Phase 2	2025-11-18		NCT04070443

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Centre Leon Berard	67

28 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Centre Hospitalier Annecy-Genevois	Annecy	France	1
Centre Hospitalier Sud Francilien	Corbeil-Essonnes	France	1
Centre Léon Bérard	Lyon	France	50
CH d'Avignon	Avignon	France	3
CH de Versailles - Hôpital André Mignot	Le Chesnay	France	1
CHRU Besançon	Besançon	France	2
CHRU Brest	Brest	France	21
CHRU Nancy/Brabois	Vandœuvre-lès-Nancy	France	1
Chu - Hopital de Pontchaillou	Rennes	France	1
CHU Amiens Picardie	Amiens	France	11
CHU d'Angers	Angers	France	27
CHU d'Estaing	Clermont-Ferrand	France	2
CHU de Grenoble	Grenoble	France	6
Chu Hotel Dieu	Nantes	France	1
CHU Limoges - Hôpital Dupuytren	Limoges	France	2
CHU Nîmes Caremeau - Institut de Cancérologie du Gard	Nîmes	France	1
CHU Poitiers	Poitiers	France	70
CHU Strasbourg	Strasbourg	France	9
Hopital Henri Mondor	Créteil	France	12
Hopital Paul Brousse	Villejuif	France	3
Hopital Saint Eloi	Montpellier	France	1
Hopital Saintantoine	Paris	France	1
Hôpital Claude Huriez - CHRU de Lille	Lille	France	1
Institut Bergonie	Bordeaux	France	23
Institut D'Hematologie de Basse Normandie	Caen	France	2

Clinical trials